Why the study?
Does a minimally invasive microdialysis test accurately diagnose malignant hyperthermia susceptibility in patients with persistent hyperCKemia?
Does a minimally invasive microdialysis test accurately diagnose malignant hyperthermia susceptibility in patients with persistent hyperCKemia?
A minimally invasive microdialysis test using halothane or caffeine can detect malignant hyperthermia susceptibility without being confounded by persistent hyperCKemia, potentially avoiding the need for surgical muscle biopsy.
Microdialysis lactate testing may distinguish MHS in hyperCKemia; hypothesis-generating and requires prospective validation before practice change.
INTRODUCTION: Persistently elevated serum creatine kinase (CK) is frequently associated with predisposition to malignant hyperthermia (MH). We investigated whether a minimally invasive metabolic test is suitable to diagnose MH susceptibility among patients with hyperCKemia. METHODS: Thirty-nine participants were included: 10 were MH susceptible (MHS); 21 MH were non-susceptible (MHN); and 8 had MHN with persistent hyperCKemia >500 U/L. Microdialysis probes were inserted into the vastus lateralis muscle, and halothane or caffeine was injected via an attached microtubing catheter. Lactate concentrations in dialysis samples were measured spectrophotometrically. RESULTS: Baseline lactate did not differ between the groups. After local application of halothane or caffeine, a significant lactate increase was detected only in the MHS group. CONCLUSIONS: Test results were not influenced by hyperCKemia. To avoid risks and complications of a surgical muscle biopsy this microdialysis test might be a useful screening tool for MH susceptibility among patients with persistent CK elevation.
No takes yet. Share an insight, caveat, or question.
Johannsen et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: